Rockefeller Capital Management
CPRX

Rockefeller Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Rockefeller Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$620K Buy
19,728
+16
+0.1% +$472 ﹤0.01% 1979
2026
Q1 		$488K Sell
19,712
-9,968
-34% -$237K ﹤0.01% 1992
2025
Q4 		$693K Buy
29,680
+6,752
+29% +$150K ﹤0.01% 1731
2025
Q3 		$452K Buy
22,928
+9,320
+68% +$192K ﹤0.01% 1819
2025
Q2 		$295K Buy
13,608
+3,239
+31% +$76.5K ﹤0.01% 1655
2025
Q1 		$251K Sell
10,369
-2,147
-17% -$48.3K ﹤0.01% 1619
2024
Q4 		$261K Buy
12,516
+45
+0.4% +$967 ﹤0.01% 1617
2024
Q3 		$248K Sell
12,471
-892
-7% -$16.5K ﹤0.01% 1575
2024
Q2 		$207K Buy
13,363
+357
+3% +$5.56K ﹤0.01% 1618
2024
Q1 		$207K Sell
13,006
-3,056
-19% -$46.1K ﹤0.01% 1657
2023
Q4 		$270K Buy
+16,062
New +$220K ﹤0.01% 1482
2023
Q3 		– Sell
-14,688
Closed -$125K – 1548
2023
Q2 		$125K Sell
14,688
-1,319
-8% -$19K ﹤0.01% 1748
2023
Q1 		$265K Buy
16,007
+15,707
+5,236% +$259K ﹤0.01% 1655
2022
Q4 		$5K Sell
300
-100
-25% -$1.54K ﹤0.01% 3315
2022
Q3 		$5K Sell
400
-200
-33% -$2.37K ﹤0.01% 3323
2022
Q2 		$4K Hold
600
– – ﹤0.01% 3518
2022
Q1 		$4K Hold
600
– – ﹤0.01% 3395
2021
Q4 		$4K Hold
600
– – ﹤0.01% 3334
2021
Q3 		$3K Hold
600
– – ﹤0.01% 3322
2021
Q2 		$3K Hold
600
– – ﹤0.01% 3146
2021
Q1 		$2K Hold
600
– – ﹤0.01% 3090
2020
Q4 		$2K Buy
+600
New +$2.02K ﹤0.01% 2622

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rockefeller Capital Management's CPRX Position: Q2 2026 in Review

Rockefeller Capital Management increased its Catalyst Pharmaceutical (CPRX) stake by 0.08% in Q2 2026, buying an estimated $472 and bringing the position to 19,728 shares worth $620K. The position accounts for ﹤0.01% of the portfolio, ranked #1979.

Rockefeller Capital Management first reported a position in CPRX in Q4 2020 and has held it in 22 quarters since. The position peaked at $693K in Q4 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Rockefeller Capital Management held 19,728 shares of Catalyst Pharmaceutical worth $620K as of Q2 2026.
  • Rockefeller Capital Management bought 16 Catalyst Pharmaceutical shares in Q2 2026, an estimated $472.
  • Catalyst Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1979 holding.
  • Rockefeller Capital Management first reported a position in Catalyst Pharmaceutical in Q4 2020 and has held it in 22 quarters since.
  • Rockefeller Capital Management's Catalyst Pharmaceutical position peaked at $693K in Q4 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.